David W. Kimberlin
- Epidemiology top 0.2%
- Herpesvirus Infections and Treatments 68
- Cytomegalovirus and herpesvirus research 65
- Influenza Virus Research Studies 19
- Respiratory viral infections research 19
- Infectious Diseases top 0.5%
- Parvovirus B19 Infection Studies 25
- Virology top 2%
- Parasitology top 1%
-
- Neonatal Health and Biochemistry 15
-
- Vaccine Coverage and Hesitancy 15
-
- Hepatitis Viruses Studies and Epidemiology 14
- Co-authors
- Richard J. WhitleyBernard RoizmanScott H. JamesSwetha PinnintiRichard F. JacobsPablo J. SánchezMark SheltonConcetta Marsico
- Journals
- New England Journal of Medicine (3 papers)PEDIATRICS (13 papers)Clinical Microbiology Reviews (1 paper)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
David W. Kimberlin
141 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Epidemiology 5.8k
- Infectious Diseases 2.6k
- Virology 382
- Parasitology 486
- Pediatrics, Perinatology and Child Health 903
Countries citing papers authored by David W. Kimberlin
This map shows the geographic impact of David W. Kimberlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Kimberlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Kimberlin more than expected).
Fields of papers citing papers by David W. Kimberlin
This network shows the impact of papers produced by David W. Kimberlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Kimberlin. The network helps show where David W. Kimberlin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David W. Kimberlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 2 | |
| 5 | 2023 | 3 | |
| 6 | Safety and efficacy of remdesivir in a pediatric covid-19 population | 2021 | 3 |
| 7 | 2019 | 27 | |
| 8 | Intranasal FluMISSED its target | 2017 | 2 |
| 9 | 2017 | 5 | |
| 10 | 2012 | 2 | |
| 11 | 2011 | 1 | |
| 12 | 2010 | 32 | |
| 13 | 2009 | 1 | |
| 14 | Oseltamivir (OST) and OST Carboxylate (CBX) Pharmacokinetics (PK) in Infants: Interim Results from a Multicenter Trial | 2009 | 7 |
| 15 | 2009 | 1 | |
| 16 | 2003 | 77 | |
| 17 | 2003 | 3 | |
| 18 | 2001 | 35 | |
| 19 | 1998 | 46 | |
| 20 | 1996 | 91 |
About David W. Kimberlin
David W. Kimberlin is a scholar working on Epidemiology, Infectious Diseases and Hepatology, having authored 153 papers that have together received 7.1k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (68 papers), Cytomegalovirus and herpesvirus research (65 papers), Parvovirus B19 Infection Studies (25 papers), Influenza Virus Research Studies (19 papers), Respiratory viral infections research (19 papers), Neonatal Health and Biochemistry (15 papers), Vaccine Coverage and Hesitancy (15 papers) and Hepatitis Viruses Studies and Epidemiology (14 papers). The work is most often cited by research in Epidemiology (5.8k citations), Infectious Diseases (2.6k citations) and Virology (382 citations). David W. Kimberlin has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Richard J. Whitley, Bernard Roizman, Scott H. James, Swetha Pinninti, Richard F. Jacobs, Pablo J. Sánchez, Mark Shelton, Concetta Marsico, Gail J. Demmler and Chin‐Yu Lin. Their work appears in journals such as New England Journal of Medicine, PEDIATRICS and Clinical Microbiology Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.